Supplier Type
- Manufacturer
- contract manufacturer
- Trader
- Reagent
- custom synthesis
Supplier Region
- Hyderabad(44)
- Ahmedabad(19)
- Maharashtra(35)
- Mallapur(1)
- New Delhi(6)
- Gujarat(40)
- Mumbai(79)
- Karnataka(6)
- Andhra Pradesh(6)
- Beijing(3)
- Delhi(12)
- Tamil Nadu(6)
- Bangalore(3)
- Telangana(5)
- Pune(7)
- Vadodara(11)
- Madhya Pradesh(2)
- Uttar Pradesh(6)
- Kolkata(4)
- Haryana(4)
- Nagpur(1)
- Kerela(1)
- West Bengal(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- PURE
- NLT 98%
- NLT 95%
- NLT 90%
- more than 95%
- more than 90%
- min 99.0%
- Min 99. 00%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Greater than 99%
- good
- Dipropargyl r- amino indane
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- ABOVE 99%
- 99.99%
- 99.98%
- 99.96%
- 99.95%
- 99.91%
- 99.90%
- 99.9%
- 99.9 %
- 99.87%
- 99.86%
- 99.85%
- 99.73%
- 99.72%
- 99.70%
- 99.67%
- 99.59%
- 99.56%
- 99.53%
- 99.52%
- 99.50%
- 99.5%+
- 99.5%
- 99.48%
- 99.45%
- 99.42%
- 99.40%
- 99.29%
- 99.04%
- 99.00%
- 99% min
- 99%
- >99%
- > 99%
- 99 % +
- 99 %
- 99
- 98+
- 98.90%
- 98.76%
- 98.70%
- 98.66%
- 98.57%
- 98.55%
- 98.54%
- 98.5 %
- 98.42%
- 98.12%
- 98.00%
- 98%+
- 98% Min
- 98%
- >98%
- 98 %
- 97-99%
- 97.81%
- 97.70%
- 97.40%
- 97.01%
- 97.00%
- >97%
- 97%
- 97 %
- 96.80%
- 96.40%
- 96.39%
- 96.31%
- 96.19%
- 96.13%
- 96.00%
- 96%
- 96 PURITY
- 95-99%
- 95-98%
- 95.63%
- 95.00%
- >95%
- 95%
- 95
- 94.07%
- 94.00%
- >92%
- 90-95%
- 90.00%
- 90%
- >90%
- 90 % Above
- 86.74%
- 86.50%
- 80-90%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 20%/24%
- 100%
- 1.0M
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 0MG TO GRAM
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1000mg
- 1g
- 1gm
- 5g
- 10g
- 25g
- 50g
- 100ml
- 100g
- 100gm
- 500gm
- 500g
- 500ml
- 1L
- 1kg
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 250kg
- 500kg
- 1000kg
- 1and gm
- 1MT
- 95NLT %
- 250250 mg.
-
3,5-Pyridinedicarboxylic acid, 4-(2-chlorophenyl)-1,4-dihydro-2-[[2-[[2-[[(2-hydroxyethyl)amino]carbonyl]benzoyl]amino]ethoxy]methyl]-6-methyl-, 3-ethyl 5-methyl ester
3079028-35-3
-
Ethyl bromoacetate
105-36-2
-
Trinexapac-ethyl
95266-40-3
-
4-Methylumbelliferone
90-33-5
-
MethanesulfonaMide, N-[4-[2-(forMylaMino)acetyl]-5-hydroxy-2-phenoxyphenyl]-
149457-03-4
-
Ethyl trifluoroacetate
383-63-1
-
3''-ACETYL-2''-HYDROXY-4-(4-PHENYLBUTOXY)BENZANILIDE
136450-06-1
-
Ethyl 2-methylthiazole-5-carboxylate
79836-78-5
-
4-HYDROXY-BUT-2-ENOIC ACID
24587-49-3
-
2-hydroxy-5-(methylthio)benzaldehyde
67868-84-2
Ethyl bromoacetate 105-36-2
Trinexapac-ethyl 95266-40-3
7-Hydroxy-4-methylcoumarin 90-33-5
N-[4-(2-Formylaminoacetyl)-5-hydroxy-2-phenoxyphenyl]methanesulfonamide 149457-03-4
Ethyl 2-methylthiazole-5-carboxylate 79836-78-5
(2E)-4-Hydroxy-2-butenoic acid 24587-49-3
Methyl ethyl ketone 78-93-3
L-Alanine ethyl ester hydrochloride 1115-59-9
(3R,4R)-1-Benzyl-4-hydroxy-3-pyrrolidinemethanol 253129-03-2